The risk of serious infection in rheumatoid arthritis patients receiving tocilizumab compared with tumor necrosis factor inhibitors in Korea

Seminars in Arthritis and Rheumatism ◽

10.1016/j.semarthrit.2021.07.004 ◽

2021 ◽

Author(s):

Ha-Lim Jeon ◽

Seoyoung C. Kim ◽

So-Hee Park ◽

Ju-Young Shin

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitors ◽

Serious Infection ◽

Necrosis Factor

Download Full-text

The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database

Rheumatology International ◽

10.1007/s00296-014-3045-8 ◽

2014 ◽

Vol 34 (12) ◽

pp. 1729-1736 ◽

Author(s):

Ryoko Sakai ◽

◽

Soo-Kyung Cho ◽

Toshihiro Nanki ◽

Ryuji Koike ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitors ◽

Serious Infection ◽

Necrosis Factor ◽

Download Full-text

Risk of Serious Infection Among Initiators of Tumor Necrosis Factor Inhibitors Plus Methotrexate Versus Triple Therapy for Rheumatoid Arthritis: A Cohort Study

Arthritis Care & Research ◽

10.1002/acr.24038 ◽

2020 ◽

Vol 72 (10) ◽

pp. 1383-1391 ◽

Author(s):

Eun Ha Kang ◽

Yinzhu Jin ◽

Angela Y. Tong ◽

Rishi J. Desai ◽

Seoyoung C. Kim

Keyword(s):

Rheumatoid Arthritis ◽

Cohort Study ◽

Tumor Necrosis Factor ◽

Triple Therapy ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitors ◽

Serious Infection ◽

Necrosis Factor

Download Full-text

The Effects of Tumor Necrosis Factor Inhibitors on Cardiovascular Risk in Rheumatoid Arthritis

Current Pharmaceutical Design ◽

10.2174/138161212799504786 ◽

2012 ◽

Vol 18 (11) ◽

pp. 1502-1511 ◽

Author(s):

Mike J.L. Peters ◽

Alper M. van Sijl ◽

Alexandre E. Voskuyl ◽

Naveed Sattar ◽

Yvo M. Smulders ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cardiovascular Risk ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors

Arthritis & Rheumatology ◽

10.1002/art.38617 ◽

2014 ◽

Vol 66 (7) ◽

pp. 1693-1704 ◽

Author(s):

Mark C. Genovese ◽

Maria Greenwald ◽

Chul-Soo Cho ◽

Alberto Berman ◽

Ling Jin ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Randomized Study ◽

Biologic Agents ◽

Interleukin 17 ◽

Inadequate Response ◽

Tumor Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

AB0379 Laboratory Safety of Adalimumab and Other Tumor Necrosis Factor Inhibitors in the Treatment of Rheumatoid Arthritis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.2051 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 931-931 ◽

Author(s):

D.A. Pappas ◽

J.W. Shaw ◽

H. Chang ◽

M.A. Cifaldi ◽

G.W. Reed ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitors ◽

Laboratory Safety ◽

Necrosis Factor

Download Full-text

Observational Studies on the Risk of Cancer Associated With Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Review of Their Methodologies and Results

Yearbook of Medicine ◽

10.1016/j.ymed.2012.09.030 ◽

2012 ◽

Vol 2012 ◽

pp. 7-8

Author(s):

R.S. Panush

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Observational Studies ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitors ◽

Risk Of Cancer ◽

Necrosis Factor

Download Full-text

Review of Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis

The Journal of the Korean Rheumatism Association ◽

10.4078/jkra.2007.14.1.1 ◽

2007 ◽

Vol 14 (1) ◽

pp. 1 ◽

Author(s):

Jung-Soo Song

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?

Drug Design Development and Therapy ◽

10.2147/dddt.s204730 ◽

2019 ◽

Vol Volume 13 ◽

pp. 2111-2125 ◽

Author(s):

Ying Huang ◽

Weiji Lin ◽

Zhe Chen ◽

Yu Wang ◽

Yao Huang ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Interstitial Lung Disease ◽

Tumor Necrosis Factor ◽

Lung Disease ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Tumor Necrosis Factor Inhibitors for Rheumatoid Arthritis

New England Journal of Medicine ◽

10.1056/nejmc062500 ◽

2006 ◽

Vol 355 (19) ◽

pp. 2046-2048 ◽

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

PAR7 SURVEY OF CURRENT TREATMENT PRACTICES OF RHEUMATOLOGISTS IN PRESCRIBING TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Value in Health ◽

10.1016/s1098-3015(10)62901-4 ◽

2005 ◽

Vol 8 (3) ◽

pp. 341-342

Author(s):

KM Kamal ◽

SM Madhavan ◽

JAA Hornsby

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Current Treatment ◽

Tumor Necrosis Factor Inhibitors ◽

Treatment Practices ◽

Necrosis Factor

Download Full-text